Sands Capital Ventures Discovery Fund Iii, L.p. - Net Worth and Insider Trading
Sands Capital Ventures Discovery Fund Iii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sands Capital Ventures Discovery Fund Iii, L.p. owns 1 companies in total, including Acumen Pharmaceuticals Inc (ABOS) .
Insider Ownership Summary of Sands Capital Ventures Discovery Fund Iii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-06-30 | 10 percent owner |
Sands Capital Ventures Discovery Fund Iii, L.p. Trading Performance
Sands Capital Ventures Discovery Fund Iii, L.p. Ownership Network
Ownership Network List of Sands Capital Ventures Discovery Fund Iii, L.p.
Ownership Network Relation of Sands Capital Ventures Discovery Fund Iii, L.p.
Sands Capital Ventures Discovery Fund Iii, L.p. Owned Company Details
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Sands Capital Ventures Discovery Fund Iii, L.p. is the 10 percent owner of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , director & President and CEO Daniel Joseph Oconnell , and Chief Financial Officer Matt Zuga .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Sands Capital Ventures Discovery Fund Iii, L.p. made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .
In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
Sands Capital Ventures Discovery Fund Iii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Sands Capital Ventures Discovery Fund Iii, L.p.. You might contact Sands Capital Ventures Discovery Fund Iii, L.p. via mailing address: C/o Sands Capital Ventures, Llc, 1000 Wilson Boulevard, Suite 3000, Arlington Va 22209.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
